Skip to content

Relationship of HHV-6B Virus to Seizures and Brain Injury

HHV6B in Epilepsy Imaging and CSF Studies

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00597285
Enrollment
33
Registered
2008-01-18
Start date
2008-01-03
Completion date
2013-11-01
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, HHV6B Infection

Keywords

18-F-Fluoro-2-Deoxy-D-Glucose (FDG), Magnetic Resonance, Epilepsy, HHV-6B, Healthy Volunteer, HV

Brief summary

This study will look for evidence that a virus called HHV-6B may be related to seizures and to a form of brain injury called mesial temporal sclerosis that is associated with seizures. The study will use new, more sensitive brain scans to try to detect brain regions that might be affected by the virus and will examine cerebrospinal fluid (CSF, the fluid that bathes the brain and spinal cord) for evidence of the virus as well. Healthy volunteers and people with seizures uncontrolled by anti-epileptic drugs who are between 18 and 45 years of age may be eligible for this study. Candidates are screened with a physical examination and laboratory tests. Participants undergo the following procedures: * PET scan. This test uses a radioactive chemical called 18FDG, which is detected by the PET scanner to obtain images of the brain. The subject lies on a table with his or her head positioned in the scanner. A swimming cap with a small light reflector is placed on the head to monitor the position of the head during the scan. A catheter (plastic tube) is inserted into an artery at the wrist or elbow crease of the arm for obtaining blood samples during the scan, and a second catheter is placed in a vein in the other arm for injecting the 18FDG. The scan takes up to 2 hours. A second scan may be done over an additional 15 minutes. * MRI. This test uses a strong magnetic field and radio waves to obtain images of the brain. The subject lies on a table that can slide in and out of a metal cylinder surrounded by a magnetic field. Most scans last between 45 and 90 minutes. * Lumbar puncture. The subject sits upright or lies on a table with the knees curled to the chest for this procedure. A local anesthetic is injected to numb the skin and a needle is inserted in the space between the bones in the lower back where the CSF circulates below the spinal cord. A small amount of fluid is collected through the needle. * Blood tests. About 4 tablespoons of blood are drawn for viral tests.

Detailed description

Objectives: 1) to attempt to detect specific patterns of hippocampal injury in patients with temporal lobe epilepsy that may be associated with HHV-6B infection; 2) To attempt to detect evidence for persistent HHV6 infection in CSF in patients with refractory temporal lobe epilepsy. 3) to obtain preliminary pilot data on the ability of high resolution structural to detect abnormalities in epilepsy patients not seen with standard scanners. Study Population: 45 patients with localization-related epilepsy; 45 healthy volunteers Design: 1) imaging with a 7T MRI magnetic resonance scanner; 2) Lumbar puncture. 3) blood sampling Main outcome measure: 1) Detection of evidence for HHV6 infection in CSF

Interventions

None listed

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS)
Lead SponsorNIH

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* INCLUSION CRITERIA: Patients will be avaluated for participation under screening protocol 01-N-0139. Patients Male and female subjects age 18 to 55 Subjects with seizures uncontrolled by antiepileptic drugs Subjects with no other illnesses, or taking other substances or medicines that could interfere with the study Healthy Controls Male and female subjects age 18 to 55.

Exclusion criteria

Patient Subjects who are pregnant or breast feeding. Subjects with any medical condition that could interfere with the study. Subjects who are taking drugs that significantly reduce blood clotting such as Coumadin or Warfarin. Healthy Volunteers Subjects who are pregnant or breast feeding Subjects who have any medical condition or be taking any substance or medication that could interfere with the study Subjects who are taking drugs that significantly reduce blood cloting such as Coumadin or Warfarin

Design outcomes

Primary

MeasureTime frame
Detection of evidence for HHV6 infection in CSF

Secondary

MeasureTime frame
Detection of lesions on 7T compared to 3T MRI

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026